Bile acid promotes intestinal metaplasia and gastric carcinogenesis

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 11, 2012, Pages 2101-2107

  Tatsugami, Masana ^a   Ito, Masanori ^a   Tanaka, Shinji ^b   Yoshihara, Masaharu ^c   Matsui, Hirofumi ^d   Haruma, Ken ^e   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CINC1 PROTEIN; GLYCOCHENODEOXYCHOLIC ACID; PROTEIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CANCER PATIENT; COHORT ANALYSIS; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; JAPANESE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH JUICE;

BILE ACIDS AND SALTS; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; FEMALE; GASTRIC JUICE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH; STOMACH NEOPLASMS;

EID: 84869209700     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0730     Document Type: Article

References (38)

1. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et al. Japanese Society for Helicobacter Research. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1-20.
2. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:37-43.
3. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1- 15.
4. Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 2006;41:1-9.
5. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005;589:47-65 (Pubitemid 40094591)
6. Kuwahara A, Saito T, Kobayashi M. Bile acids promote carcinogenesis in the remnant stomach of rats. J Cancer Res Clin Oncol 1989;115:423-28. (Pubitemid 19246605)
7. Kondo K. Duodenogastric reflux and gastric stump carcinoma. Gastr Cancer 2002;5:16-22. (Pubitemid 34496347)
8. Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon ATR. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002;51:351-5.
9. Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999;44:598-602. (Pubitemid 29195903)
10. Gillen P, Keeling P, Byrne PJ, Healy M, O'Moore RR, Hennessy TP. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg 1988;75:540-3.
11. Iftikhar SY, Ledingham S, Steele RJ, Evans DF, Lendrum K, Atkinson M, et al. Bile refl ux in columnar-lined Barrett's oesophagus. Ann R Coll Surg Engl 1993;75:411-6. (Pubitemid 23323448)
12. Komichi D, Tazuma S, Nishioka T, Hyogo H, ChayamaK. Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. Free Radic Biol Med 2005;39:1418-27. (Pubitemid 41547222)
13. Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 2000;119:961-71.
14. Macdonald PM, Struhl G. A molecular gradient in early Drosophila embryos and its role in specifying the body pattern. Nature 1986;324:537-45. (Pubitemid 17185068)
15. Moreno E, Morata G. Caudal is the Hox gene that specifies the most posterior Drosophile segment. Nature 1999;400:873-7. (Pubitemid 29406723)
16. Mutoh H, Hakamata Y, Sato K, Eda A, Yanaka I, Honda S, et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 2002;294:470-9. (Pubitemid 34694118)
17. Handa O, Naito Y, Takagi T, Shimozawa M, Kokura S, Yoshida N, et al. Tumor necrosis factor-alpha-induced cytokine-induced neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor-kappaB. J Pharmacol Exp Ther 2004;309:670-6. (Pubitemid 38542621)
18. Mashige F, Imai K, Osuga T.Asimple and sensitive assay of total serum bile acids. Clin Chim Acta 1976;70:79-86.
19. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161- 81.
20. Xie XF, Ito M, Sumii M, Tanaka S, Yoshihara M, Chayama K. Helicobacter pylori-associated gastritis is related to babA2 expression without heterogeneity of the 30 region of the cagA genotype in gastric biopsy specimens. Pathobiology 2007;74:309-16. (Pubitemid 47450577)
21. Hsieh CS, Huang CC, Huang LT, Tsai YJ, Chou MH, Chuang JH. Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats. J Pediatr Surg 2004;39:10-5.
22. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarençon D, et al. Rat pro-in flammatory cytokine and cytokine related mRNA quanti fication by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004;5:3.
23. Xu Y, Watanabe T, Tanigawa T, Machida H, Okazaki H, Yamagami H, et al. Bile acids induce cdx2 expression through the farnesoid x receptor in gastric epithelial cells. J Clin Biochem Nutr 2010;46:81-6.
24. Kazumori H, Ishihara S, Kinoshita Y. Roles of caudal-related homeo-box gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut 2009;58:620-8.
25. Nakamura M, Haruma K, Kamada T, Mihara M, Yoshihara M, Imagawa M, et al. Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 2001;53:53-9. (Pubitemid 32109450)
26. Thao TD, Ryu HC, Yoo SH, Rhee DK. Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis. Biochem Pharmacol 2008;75:2135-46.
27. Suzuki H, Mori M, Seto K, Shibata F, Nagahashi S, Kawaguchi C, et al. Rat CXC chemokine GRO/CINC-1 paradoxically stimulates the growth of gastric epithelial cells. Aliment Pharmacol Ther 2000;14(Suppl 1):94-100. (Pubitemid 30199112)
28. Naito Y, Ito M, Watanabe T, Suzuki H. Biomarkers in patients with gastric inflammation: a systematic review. Digestion 2005;72:164-80. (Pubitemid 41507277)
29. Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res 1999;5:1411- 5.
30. Park WI, Park MJ, An JK, Choi YH, Kim HY, Cheong J, et al. Bile acid regulates c-Jun expression through the orphan nuclear receptor SHP induction in gastric cells. Biochem Biophys Res Commun 2008;369:437-43.
31. Kajiyama G, Fujiyama M, Ohe K. Changes of bile acids and phospholipids in gastric juice in patients with gastric ulcer, duodenal ulcer and atrophic gastritis. Igaku-hokan (in Japanese) 1979:26;325-33. (Pubitemid 10091330)
32. Heaton KW. Bile salts in health and disease. Basic chemistry and distribution. Churchill Livingstone; 1972. p. 14-23.
33. Harmon JW, Doong T, Gadacz TR. Bile acid are not equally damaging to the gastric mucosa. Surgery 1978,84;7986.
34. Matsumoto Y, Ito M, Kamino D, Tanaka S, Haruma K, Chayama K. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography. J Gastroenterol 2008;43:332-7. (Pubitemid 351958896)
35. Dowling RH, Small DM. The effect of pH on the solubility of varying mixtures of free and conjugated bile acids in solution. Gastroenterology 1968;54;1291.
36. Graham DY, Asaka M. Eradication of gastric cancer and more effi cient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol 2010;45:1-8.
37. Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009;44:365-71.
38. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011;16:415-9.